These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8340254

  • 1. Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115).
    Noguchi S, Nishizawa Y, Motomura K, Inaji H, Imaoka S, Koyama H, Matsumoto K.
    Jpn J Cancer Res; 1993 Jun; 84(6):656-63. PubMed ID: 8340254
    [Abstract] [Full Text] [Related]

  • 2. Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).
    Fujita MQ, Yasui T, Sato B, Uchida N, Uchida K, Shiratori O, Takeda K, Matsumoto K.
    Jpn J Cancer Res; 1992 Sep; 83(9):995-1001. PubMed ID: 1429212
    [Abstract] [Full Text] [Related]

  • 3. Action mechanisms of physiological doses of androgen or pharmacological doses of estrogen in growth stimulation of Shionogi carcinoma 115 in mice.
    Nakamura N, Nishizawa Y, Noguchi S, Uchida N, Sato B, Matsumoto K.
    J Steroid Biochem; 1987 Sep; 27(1-3):459-64. PubMed ID: 2961936
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Takatsuka D, Kitamura Y, Terada N, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1985 Oct; 45(10):4785-90. PubMed ID: 4027967
    [Abstract] [Full Text] [Related]

  • 5. Progression of androgen-sensitive mouse tumor (Shionogi carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone.
    Sato N, Watabe Y, Suzuki H, Shimazaki J.
    Jpn J Cancer Res; 1993 Dec; 84(12):1300-8. PubMed ID: 8294220
    [Abstract] [Full Text] [Related]

  • 6. Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice.
    Noguchi S, Nishizawa Y, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5746-50. PubMed ID: 4053046
    [Abstract] [Full Text] [Related]

  • 7. Androgen receptor system in androgen-independent mouse tumor developed from androgen-dependent Shionogi carcinoma 115.
    Seike H, Takeuchi M, Kitamura Y, Sato B, Yamaguchi K, Matsumoto K.
    Anticancer Res; 1983 Nov; 3(1):35-9. PubMed ID: 6830149
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of androgen-independent growth of androgen-responsive Shionogi carcinoma 115 cells.
    Tomioka S, Ichikawa T, Watabe Y, Suzuki H, Shimazaki J.
    Int J Urol; 1996 Jul; 3(4):286-91. PubMed ID: 8844285
    [Abstract] [Full Text] [Related]

  • 9. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S, Nishizawa Y, Nakamura N, Uchida N, Yamaguchi K, Sato B, Kitamura Y, Matsumoto K.
    Cancer Res; 1987 Jan 01; 47(1):263-8. PubMed ID: 3791211
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
    Hiraoka D, Nakamura N, Nishizawa Y, Uchida N, Noguchi S, Matsumoto K, Sato B.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6560-4. PubMed ID: 3677094
    [Abstract] [Full Text] [Related]

  • 11. Effects of antiandrogens on growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115) in vivo and in vitro.
    Suzuki T, Horibe I, Uchida N, Ezumi K, Uchida K, Takeda K, Tanaka A, Nishizawa Y, Matsumoto K.
    J Steroid Biochem Mol Biol; 1990 Nov 30; 37(4):559-67. PubMed ID: 2278840
    [Abstract] [Full Text] [Related]

  • 12. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture.
    Omukai Y, Nakamura N, Hiraoka D, Nishizawa Y, Uchida N, Noguchi S, Sato B, Matsumoto K.
    Cancer Res; 1987 Aug 15; 47(16):4329-34. PubMed ID: 3607765
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
    Weckbecker G, Liu R, Tolcsvai L, Bruns C.
    Cancer Res; 1992 Sep 15; 52(18):4973-8. PubMed ID: 1325289
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Androgen dependency of a tumor produced by a cell line derived from androgen-responsive Shionogi carcinoma 115.
    Terada N, Yamamoto R, Uchida N, Takada T, Taniguchi H, Takatsuka D, Sawada M, Tsuji M, Li W, Kitamura Y.
    Cancer Res; 1989 Feb 01; 49(3):693-8. PubMed ID: 2910490
    [Abstract] [Full Text] [Related]

  • 18. Effects of steroid hormones and opioid peptides on the growth of androgen-responsive Shionogi carcinoma (SC115) cells in primary culture.
    Jiang Y, Weinberg J, Wilkinson DA, Emerman JT.
    Cancer Res; 1993 Sep 15; 53(18):4224-9. PubMed ID: 8364918
    [Abstract] [Full Text] [Related]

  • 19. Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi carcinoma 115.
    Kitamura Y, Uchida N, Hayata I, Yamaguchi K, Okamoto S, Narita N, Matsumoto K.
    Cancer Res; 1980 Dec 15; 40(12):4781-5. PubMed ID: 7438110
    [Abstract] [Full Text] [Related]

  • 20. Changes in cytosolic androgen receptor after administration of testosterone of androgen-dependent mouse mammary tumor (Shionogi carcinoma) and its sublines of altered androgen dependency.
    Fuse H, Akimoto S, Sato R, Miyauchi T, Wakisaka M, Hosoya T, Shimazaki J.
    Endocrinol Jpn; 1983 Apr 15; 30(2):189-97. PubMed ID: 6605848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.